Cancer Research KI list of cancer research PIs across KI, H to S
Please find the head and neck cancer, health care sciences within cancer, Kidney cancer, liver bile and duct cancers, lung cancer, muscoskeletal cancer, prostate cancer, sarcomas, and skin cancer researchers at KI listed in the tables below.
Note that this is an initial list that may still contain errors in part because the response rate on the conducted survey was below a hundred per cent. We would therefore like you to be in contact with us if you find that your name has been erroneously entered or if you would like to complete the current information in any way. Please send your update request to cancerresearchki@ki.se.
Contact details for the researchers can be found through the KI search function on the top right-hand side of this page.
Head and neck cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Lars-Olaf | Cardell | lars-olaf.cardell@ki.se | Department of Clinical Science, Intervention and Technology (ClinTec) | Introduction of immunological markers in lymph nodes for staging and therapeutics selection in head and neck cancer. | |
| Tina | Dalianis | Tina.Dalianis@ki.se | Department of Oncology-Pathology (Onk-Pat) | I study all aspects of human papillomavirus (HPV) induced cancer, especially head neck cancer aiming to find prognostic and targetable biomarkers to better individualise therapy, increase survival and quality of life. I also have a general interest in virus induced cancer and all aspects of the immune system. | https://ki.se/en/onkpat/tina-dalianis-group |
| Caroline | Gahm | caroline.gahm@ki.se | Department of Clinical Science, Intervention and Technology (ClinTec) | ||
| Karin | Garming Legert | karin.garming.legert@ki.se | Department of Dental Medicine (DentMed) | ||
| Eva | Munck Af Rosenschöld Wikland | eva.munck-wikland@ki.se | Department of Clinical Science, Intervention and Technology (ClinTec) | ||
| Rachael | Sugars | rachael.sugars@ki.se | Department of Dental Medicine (DentMed) | Developing clinical and pathological diagnostics for oral complications after hematopoietic cell transplantation in the form of Graft versus Host Disease (GVHD). Clinical studies along with the use of machine learning approaches work to refine oral mucosal and salivary gland cGVHD pathogenesis, diagnostic criteria and the search for predictive biomarkers. | https://ki.se/en/dentmed/oral-biology-and-medicine-group |
| Weimin | Ye | weimin.ye@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Gustav | Stålhammar | gustav.stalhammar@ki.se | Department of Clinical Neuroscience (CNS) | We conduct clinical and preclinical research to expand knowledge, improve survival and reduce suffering in eye cancer and diseases of the eyelids and lacrimal system. | https://ki.se/en/cns/ocular-oncology-and-pathology |
Health Care Sciences, cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Linda | Björkhem-Bergman | linda.bjorkhem-bergman@ki.se | Department of Neurobiology, Care Sciences and Society (NVS) | Cancer research in Palliative Care. Clinical and translational studies. | https://medarbetare.ki.se/orgid/53012309 |
| Pernilla | Lagergren | pernilla.lagergren@ki.se | Department of Molecular Medicine and Surgery (MMK) | We are investigating factors that influence survivorship after oesophageal and gastric cancer in order to personalise and individualise the care after cancer. | https://ki.se/en/mmk/surgical-care-science |
| Claudia | Lampic | claudia.lampic@ki.se | Department of Women's and Children's Health (KBH) | Focus on survivorship and quality of life in young adults with cancer. Leads research program Fertility and sexuality following cancer (Fex-Can). | https://ki.se/en/kbh/fex-can-fertility-and-sexuality-following-cancer |
| Ann | Langius-Eklöf | ann.langius-eklof@ki.se | Department of Neurobiology, Care Sciences and Society (NVS) | To evaluate the effects of routine use of an app of diagnose/treatment related symptoms and concerns regarding symptom burden, quality of life, cost-effectiveness and survival. | https://ki.se/nvs/icare |
| Annika | Lindahl Norberg | annika.lindahl.norberg@ki.se | Institute of Environmental Medicine (IMM) | ||
| Pernilla | Pergert | pernilla.pergert@ki.se | Department of Women's and Children's Health (KBH) | We perform childhood cancer healthcare research, focusing on intercultural care & clinical ethics. | https://ki.se/en/kbh/childhood-cancer-healthcare-research |
| Lena | Sharp | lena.sharp@ki.se | Department of Learning, Informatics, Management and Ethics (LIME) | ||
| David | Tamborero | david.tamborero@ki.se | Department of Oncology-Pathology (Onk-Pat) | > analyses of omics data to better understand cancer mechanisms and therapeutic opportunities> development of bioinformatic tools to support the clinical decision making | https://ki.se/en/onkpat/janne-lehtios-group |
| Carol | Tishelman | carol.tishelman@ki.se | Department of Learning, Informatics, Management and Ethics (LIME) | I am primarily working with end-of-life care issues from a public health palliative care perspective at present.This research line is not cancer-specific.I have previously researched symptom experiences, primarily related to lung cancer, as well as secondary cancer prevention | https://www.xn--dbra-5qa.se/en/ |
Kidney (renal cell) and urinary tract cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Andreas | Lundqvist | andreas.lundqvist@ki.se | Department of Oncology-Pathology (Onk-Pat) | Our research focus on studies to understand how natural killer cells and T cells are regulated in patients with cancer. With this knowledge we aim to develop improved immunotherapies in patients with cancer. | https://ki.se/en/onkpat/andreas-lundqvists-group |
| Lars | Egevad | lars.egevad@ki.se | Department of Oncology-Pathology (Onk-Pat) |
Liver Bile duct Pancreas cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Soo | Aleman | soo.aleman@ki.se | Department of Medicine, Huddinge (MedH) | ||
| Emma | Andersson | emma.andersson@ki.se | Department of Cell and Molecular Biology (CMB) | ||
| Annika | Bergquist | annika.bergquist@ki.se | Department of Medicine, Huddinge (MedH) | Biomarkets for eraly detection of cholangiocarcinoma | https://ki.se/en/medh/annika-bergquist-group |
| Ulf | Eriksson | ulf.pe.eriksson@ki.se | Department of Medical Biochemistry and Biophysics (MBB) | The role of obesity ans diabetes on cancer development, focussing on the liver and liver cancer | |
| Marco | Gerling | marco.gerling@ki.se | Department of Biosciences and Nutrition (BioNut) | ||
| Karin | Lindahl | karin.lindahl@ki.se | Department of Medicine, Huddinge (MedH) | ||
| Matti | Sällberg | matti.sallberg@ki.se | Department of Laboratory Medicine (LabMed) | ||
| Margaret | Sällberg Chen | margaret.chen@ki.se | Department of Dental Medicine (DentMed) | Targeting cancer-associated pathogens for early cancer prevention and treatment | |
| Johan | Sandberg | johan.sandberg@ki.se | Department of Medicine, Huddinge (MedH) | We investigate the role of unconventional T cells (MAIT cells) in tissues, tumors and treatment. | https://ki.se/en/medh/johan-sandberg-group |
| Ernesto | Sparrelid | ernesto.sparrelid@ki.se | Department of Clinical Science, Intervention and Technology (ClinTec) | Liver and pancreatic cancer surgery, liver regeneration, liver immunology and pancreatic cystic lesions. Both clinical and translational research. | |
| Miroslav | Vujasinovic | Miroslav Vujasinovic | Department of Medicine, Huddinge (MedH) | ||
| Niklas | Björkström | niklas.bjorkstrom@ki.se | Department of Medicine, Huddinge (MedH) | We study human tumor immunology with a focus on liver cancer making use of rare fresh clinical tissue samples and the latest single cell methods. | https://ki.se/en/medh/niklas-bjorkstrom-group-human-tissue-resident-nk-… |
| Per | Stål | per.stal@ki.se | Department of Medicine, Huddinge (MedH) | Blood-bourne biomarkers for early detection of hepatocellular carcinoma.Prognostic biomarkers for treatment response of hepatocelluler carcinoma. | https://ki.se/en/medh/stal-and-wahlin-group |
Lung cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Isabel | Barragán | isabel.barragan@ki.se | Department of Physiology and Pharmacology (Fyfa) | Identification of molecular biomarkers of response to cancer immunotherapy. Generation of reponse and prognosis prediction models combining molecular and clinicopathological variables. Abscopal response mechanisms. Any cancer treated with immunotherapy. | https://ki.se/en/fyfa/pharmacoepigenetics |
| Britt-Marie | Bernhardson | britt-marie.bernhardson@ki.se | Department of Learning, Informatics, Management and Ethics (LIME) | ||
| Luigi | De Petris | luigi.depetris@ki.se | Department of Oncology-Pathology (Onk-Pat) | Clinical factors of importance for immunotherapy in non-small cell (NSCLC), and biomarker studies in relation to treatment pathways in small-cell lung cancer (SCLC) | https://ki.se/en/onkpat/research-team-luigi-de-petris |
| Katalin | Dobra | katalin.dobra@ki.se | Department of Laboratory Medicine (LabMed) | My focus is molecular profiling and understanding of cell-matrix interactions in aggressive mesenchymal tumours. By molecular modifications we can revert this EMT like phenomenon and tumour cells achieve an epithelioid differentiation. I also study both in experimental and clinical settings various tumor driving mutations and angiogenic factors and by combining various genome wide analyses with ex vivo drug sensitivity/resistence profiling we can pinpoint individual fingerprints of tumours and match them with the best suited individualised therapy. | https://ki.se/en/labmed/research-group-katalin-dobra |
| Simon | Ekman | simon.ekman@ki.se | Department of Oncology-Pathology (Onk-Pat) | ||
| Lars E. | Eriksson | lars.eriksson@ki.se | Department of Learning, Informatics, Management and Ethics (LIME) | Translational aspects with patient reported outcome measures and biomarkers | https://ki.se/en/lime/division-of-innovative-care-research |
| Bo | Franzén | bo.franzen@ki.se | Department of Oncology-Pathology (Onk-Pat) | 3. Development of fine needle based molecular cytology for personalized cancer medicine:https://ki.se/en/onkpat/research-team-lewensohnviktorssonlindberg | https://ki.se/en/onkpat/research-team-lewensohnviktorssonlindberg |
| Per | Hydbring | per.hydbring@ki.se | Department of Oncology-Pathology (Onk-Pat) | To investigate novel RNA-based therapies and RNA-based diagnostics in non-small cell lung cancer. | |
| Veronica | Jackson | Veronica.Jackson@ki.se | Department of Molecular Medicine and Surgery (MMK) | Outcome following thoraic cancer surgery | https://ki.se/mmk/thoraxkirurgi |
| Janne | Lehtiö | janne.lehtio@ki.se | Department of Oncology-Pathology (Onk-Pat) | Cancer proteogenomics from methods development to biological and translational research. Connecting molecular phenotype, proteome level information to improve targeted and immunotherapy in cancer. | https://ki.se/en/onkpat/janne-lehtios-group |
| Rolf | Lewensohn | rolf.lewensohn@ki.se | Department of Oncology-Pathology (Onk-Pat) | ||
| Karin | Lindberg | karin.lindberg@ki.se | Department of Oncology-Pathology (Onk-Pat) | Integration of stereotactic body radiation therapy (SBRT) in the metastastic setting and evaluation of SBRT to centrally located lung lesions. | https://ki.se/en/onkpat/research-team-lewensohnviktorssonlindberg |
| Knut | Lönnroth | knut.lonnroth@ki.se | Department of Global Public Health (GPH) | ||
| Nicole | Marquardt | nicole.marquardt@ki.se | Department of Medicine, Huddinge (MedH) | We strive towards a better understanding on the immunological landscape within the human lung. | https://ki.se/en/medh/team-nicole-marquardt-human-tissue-resident-nk-ce… |
| Erik | Norberg | Helin.Norberg@ki.se | Department of Physiology and Pharmacology (Fyfa) | The main focus of our research is to dissect the cells own quality control mechanisms to develop novel therapeutic strategies to selectively target pathogenic proteins in cancer. | https://ki.se/en/fyfa/helin-norberg-lab-protein-degradation-pathways |
| Ulla | Stenius | Ulla.Stenius@ki.se | Institute of Environmental Medicine (IMM) | ||
| Kristina | Viktorsson | kristina.viktorsson@ki.se | Department of Oncology-Pathology (Onk-Pat) | Analyses of Ephrin/Eph and extracelluar vesicles for lung cancer biomarkers. | https://ki.se/en/onkpat/research-team-lewensohnviktorssonlindberg |
| Boris | Zhivotovsky | boris.zhivotovsky@ki.se | Institute of Environmental Medicine (IMM) | Why some tumor cells are resistant to cell death? |
Musculoskeletal cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Larsson | Lars | lars.larsson@ki.se | Department of Physiology and Pharmacology (Fyfa) | Mechanmisms underlying cancer cachexia. Intervention strategies. | |
| Panagiotis | Tsagkozis | panagiotis.tsagkozis@ki.se | Department of Molecular Medicine and Surgery (MMK) | Bone and soft-tissue sarcomas. Bone metastases and pathological fracture treatment. | |
| Rikard | Wedin | Rikard.wedin@ki.se | Department of Molecular Medicine and Surgery (MMK) | AI-baserade Prognostiska beslutsstöd för behandling av skelettmetastaspatienter.Registerhållare RCC’s Internationella register för kirurgiskt behandlade skelettmetastaspatienter. |
Prostate cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Olof | Akre | olof.akre@ki.se | Department of Molecular Medicine and Surgery (MMK) | ||
| Stephanie | Bonn | stephanie.bonn@ki.se | Department of Medicine, Solna (MedS) | ||
| Stefan | Carlsson | stefan.carlsson@ki.se | Department of Molecular Medicine and Surgery (MMK) | Improve diagnosing prostate cancer. | https://medarbetare.ki.se/orgid/5201150 |
| Mark | Clements | mark.clements@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | Health economic evaluation of cancer screening | |
| Martin | Eklund | martin.eklund@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Henrik | Grönberg | henrik.gronberg@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Jan-Åke | Gustafsson | jan-ake.gustafsson@ki.se | Department of Biosciences and Nutrition (BioNut) | ||
| Ove | Gustafsson | ove.gustafsson@ki.se | Department of Clinical Science, Intervention and Technology (ClinTec) | ||
| Johan | Lindberg | johan.lindberg@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | Broad DNA- and RNA sequencing in the context of randomised clinical trials and retrospective research on large cohorts. | |
| Sten | Nilsson | sten.nilsson@ki.se | Department of Oncology-Pathology (Onk-Pat) | ||
| Fredrik | Wiklund | fredrik.wiklund@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | Population-based genetic epidemiological studies of testicular and prostate cancer. | |
| Peter | Wiklund | Peter.Wiklund@ki.se | Department of Molecular Medicine and Surgery (MMK) |
Sarcomas research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Monika | Ehnman | monika.ehnman@ki.se | Department of Oncology-Pathology (Onk-Pat) | Translational studies on the sarcoma tumor microenvironment, multiplex immunostaining of patient cohorts, stromal cell and immune cell biomarkers. | http://staff.ki.se/people/monehn |
| Panagiotis | Tsagkozis | panagiotis.tsagkozis@ki.se | Department of Molecular Medicine and Surgery (MMK) | Sarcomas and metastatic bone disease |
Skin cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Suzanne | Egyhazi Brage | suzanne.egyhazi.brage@ki.se | Department of Oncology-Pathology (Onk-Pat) | Translational research in cutaneous melanoma. The main focus is identification of biomarkers to predict efficacy of targeted therapies and immunotherapies. | https://ki.se/en/onkpat/johan-hanssons-group |
| Lennart | Emtestam | lennart.emtestam@ki.se | Department of Medicine, Huddinge (MedH) | ||
| Maria | Genander | maria.genander@ki.se | Department of Cell and Molecular Biology (CMB) | We are interested in bridging normal stem and progenitor cell function to cancer. | https://ki.se/en/cmb/maria-genanders-group |
| Johan | Hansson | johan.hansson@ki.se | Department of Oncology-Pathology (Onk-Pat) | Translational research in melanoma focusing on predictive and prognostic markers. | |
| Rikard | Holmdahl | rikard.holmdahl@ki.se | Department of Medical Biochemistry and Biophysics (MBB) | Redox control of the immune response to cancer. | http://ki.se/en/mbb/research-division-of-medical-inflammation-research |
| Carlos | Ibanez | carlos.ibanez@ki.se | Department of Neuroscience (NEURO) | Physiological Roles and Signaling Mechanisms of Death Receptor p75NTR: Application to Drug Discovery in Melanoma and other Cancers | |
| Maria | Kasper | maria.kasper@ki.se | Department of Cell and Molecular Biology (CMB) | Skin cancer. We study the cellular heterogeneity, molecular signals and niche importance in healthy skin and skin cancer (BCC, SCC, Melanoma), using single-cell transcriptomics, computational biology, spatial tissue mapping, human tissue, and mouse models. | https://kasperlab.org/ |
| Rolf | Kiessling | rolf.kiessling@ki.se | Department of Oncology-Pathology (Onk-Pat) | Performing clinical cell therapy trials with TIL cells and DC tumor vaccines.Investigating tumor escape mechanisms and how to overcome these. | https://ki.se/en/onkpat/rolf-kiesslings-group |
| Stig | Ollmar | stig.ollmar@ki.se | Department of Clinical Science, Intervention and Technology (ClinTec) | ||
| Andor | Pivarcsi | andor.pivarcsi@ki.se | Department of Medicine, Solna (MedS) | We investigate the role of non-coding RNAs in different forms of skin cancers. | |
| Ulrik | Ringborg | ulrik.ringborg@ki.se | Department of Oncology-Pathology (Onk-Pat) | ||
| Stefan | Seregard | stefan.seregard@ki.se | Department of Clinical Neuroscience (CNS) | ||
| Fredrik | Wermeling | fredrik.wermeling@ki.se | Department of Medicine, Solna (MedS) | My group studies cancer drug response, including a novel immunotherapy that triggers a metabolic phenotype. We use CRISPR and CRISPR screens to find combinatorial drug targets. | |
| Gustav | Stålhammar | gustav.stalhammar@ki.se | Department of Clinical Neuroscience (CNS) | We conduct clinical and preclinical research to expand knowledge, improve survival and reduce suffering in eye cancer and diseases of the eyelids and lacrimal system. | https://ki.se/en/cns/ocular-oncology-and-pathology |
| Yvonne | Brandberg | yvonne.brandberg@ki.se | Department of Oncology-Pathology (Onk-Pat) | Professor of Care Sciences, focusing on oncology, at the Department of Oncology-Pathology. Psychologist, specialist in clinical psychology focused on measures/treatment/counseling. | https://ki.se/onkpat/yvonne-brandbergs-forskargrupp |
| Hildur | Helgadottir | hildur.helgadottir@ki.se | Department of Oncology-Pathology (Onk-Pat) | Our research is focused on malignant melanoma. We study melanoma incidence, biology, genetics and different aspects related to prevention and treatment of the disease. | https://ki.se/en/onkpat/hildur-helgadottirs-group |